Sonova Holding AG

BATS-CHIXE:SOONz Stock Report

Market Cap: CHF 18.1b

Sonova Holding Valuation

Is SOONz undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SOONz when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SOONz (CHF302.7) is trading below our estimate of fair value (CHF340.86)

Significantly Below Fair Value: SOONz is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SOONz?

Other financial metrics that can be useful for relative valuation.

SOONz key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5.3x
Enterprise Value/EBITDA23.1x
PEG Ratio3.7x

Price to Earnings Ratio vs Peers

How does SOONz's PE Ratio compare to its peers?

The above table shows the PE ratio for SOONz vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average34.9x
SN. Smith & Nephew
44.6x22.7%UK£10.2b
NIOX NIOX Group
26.1x15.8%UK£286.7m
CTEC ConvaTec Group
41.1x21.0%UK£4.7b
EKF EKF Diagnostics Holdings
28xn/aUK£133.9m
SOONZ Sonova Holding
26.6x10.7%CHF 16.0b

Price-To-Earnings vs Peers: SOONz is good value based on its Price-To-Earnings Ratio (30x) compared to the peer average (34.9x).

Price to Earnings Ratio vs Industry

How does SOONz's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a22.9%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a22.9%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: SOONz is good value based on its Price-To-Earnings Ratio (30x) compared to the European Medical Equipment industry average (30.7x).

Price to Earnings Ratio vs Fair Ratio

What is SOONz's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SOONz PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio30x
Fair PE Ratio33.5x

Price-To-Earnings vs Fair Ratio: SOONz is good value based on its Price-To-Earnings Ratio (30x) compared to the estimated Fair Price-To-Earnings Ratio (33.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SOONz forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 302.70
CHF 272.65
-9.9%
12.7%CHF 325.00CHF 200.00n/a17
Sep ’25CHF 296.80
CHF 272.65
-8.1%
12.7%CHF 325.00CHF 200.00n/a17
Aug ’25CHF 268.60
CHF 272.65
+1.5%
12.7%CHF 325.00CHF 200.00n/a17
Jul ’25CHF 280.10
CHF 272.65
-2.7%
12.7%CHF 325.00CHF 200.00n/a17
Jun ’25CHF 285.30
CHF 272.65
-4.4%
12.7%CHF 325.00CHF 200.00n/a17
May ’25CHF 256.10
CHF 272.65
+6.5%
12.7%CHF 325.00CHF 200.00n/a17
Apr ’25CHF 260.90
CHF 272.65
+4.5%
12.7%CHF 325.00CHF 200.00n/a17
Mar ’25CHF 276.00
CHF 270.59
-2.0%
13.4%CHF 325.00CHF 200.00n/a17
Feb ’25CHF 279.00
CHF 267.06
-4.3%
14.7%CHF 325.00CHF 200.00n/a16
Jan ’25CHF 274.00
CHF 257.07
-6.2%
12.7%CHF 320.00CHF 200.00n/a15
Dec ’24CHF 255.60
CHF 259.75
+1.6%
13.4%CHF 340.00CHF 200.00n/a16
Nov ’24CHF 217.40
CHF 249.50
+14.8%
15.8%CHF 340.00CHF 195.00n/a16
Oct ’24CHF 217.70
CHF 252.81
+16.1%
16.3%CHF 340.00CHF 195.00n/a16
Sep ’24CHF 233.00
CHF 253.59
+8.8%
15.4%CHF 331.00CHF 195.00CHF 296.8017
Aug ’24CHF 242.70
CHF 253.59
+4.5%
15.4%CHF 331.00CHF 195.00CHF 268.6017
Jul ’24CHF 238.70
CHF 254.76
+6.7%
14.8%CHF 331.00CHF 195.00CHF 280.1017
Jun ’24CHF 234.60
CHF 248.91
+6.1%
14.6%CHF 320.00CHF 180.30CHF 285.3018
May ’24CHF 282.30
CHF 257.58
-8.8%
15.1%CHF 330.00CHF 180.30CHF 256.1016
Apr ’24CHF 268.60
CHF 257.33
-4.2%
15.2%CHF 330.00CHF 180.30CHF 260.9016
Mar ’24CHF 231.10
CHF 258.71
+11.9%
15.4%CHF 330.00CHF 180.30CHF 276.0016
Feb ’24CHF 233.00
CHF 258.71
+11.0%
15.4%CHF 330.00CHF 180.30CHF 279.0016
Jan ’24CHF 219.40
CHF 286.21
+30.4%
20.7%CHF 450.00CHF 180.30CHF 274.0016
Dec ’23CHF 248.50
CHF 291.29
+17.2%
20.0%CHF 450.00CHF 180.30CHF 255.6015
Nov ’23CHF 234.50
CHF 305.21
+30.2%
16.9%CHF 450.00CHF 255.00CHF 217.4014
Oct ’23CHF 219.30
CHF 335.00
+52.8%
13.6%CHF 450.00CHF 257.00CHF 217.7013
Sep ’23CHF 253.10
CHF 338.08
+33.6%
13.8%CHF 450.00CHF 257.00CHF 233.0013

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y